Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Importantly, patients should never feel they have 'failed'obesity is a chronic disease requiring ongoing management, and treatment plans should be individualised and adjusted as needed
According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 Asia-Pacific is the fastest-growing region at 17.07% CAGR, driven by China's 140 million diabetics, Japan's post-PMDA approvals of Ozempic and Wegovy, and India emerging as the fastest-growing sub-market at 19.89% CAGR, leveraging GLP-1 biosimilar production
It is currently in Phase 2 clinical trials for the treatment of overweight and obesity
While ecnoglutide has not yet received formal marketing authorization for any indication in any country or region worldwide, in China, new drug applications (NDAs) are under review
Reduce hot peppers, strong spices, and acidic tomato-based sauces if you experience discomfort
